Signal Transduction Practice Questions

Q: What is a zinc finger?

Nuclear receptor. **Explanation:** **Zinc fingers** are structural motifs found in proteins that bind to DNA. They consist of a protein loop stabilized by a zinc ion coordinated to four amino acids (usually Cysteine and Histidine). These motifs act as **DNA-binding domains**, allowing proteins to recognize specific genetic sequences. 1. **Why Option A is Correct:** Nuclear receptors (e.g., steroid, thyroid, and retinoic acid receptors) function as ligand-activated transcription factors. Once a hormone binds to the receptor, the receptor uses its **zinc finger motifs** to bind to specific "Hormone Response Elements" (HRE) on the DNA to regulate gene expression. Therefore, zinc fingers are a hallmark structural feature of the DNA-binding domain of **Nuclear Receptors**. 2. **Why Other Options are Incorrect:** * **Option B (Membrane Receptors):** These (like GPCRs) span the lipid bilayer and interact with extracellular ligands. They do not bind directly to DNA and thus do not utilize zinc finger motifs. * **Option C (Receptor Associated Kinases):** These (like JAK-STAT or Tyrosine Kinase receptors) function via phosphorylation cascades in the cytoplasm/membrane, not via direct DNA-binding structural motifs like zinc fingers. **High-Yield Clinical Pearls for NEET-PG:** * **Common Motifs:** Other DNA-binding motifs include the **Leucine Zipper** (e.g., AP-1, c-jun/c-fos) and **Helix-Turn-Helix** (common in homeodomain proteins). * **Steroid Receptors:** All steroid receptors (Estrogen, Progesterone, Glucocorticoid) are classic examples of proteins containing zinc fingers. * **Vitamin D:** The Vitamin D receptor (VDR) also utilizes zinc fingers; mutations here can lead to Vitamin D-resistant rickets.

Q: What are G-proteins?

Membrane regulators. **Explanation:** **G-proteins (Guanine nucleotide-binding proteins)** act as molecular switches that transmit signals from the extracellular environment to the interior of the cell. They are classified as **membrane regulators** because they function as transducers, coupling the activation of G-protein-coupled receptors (GPCRs) to the regulation of downstream effector enzymes (like Adenylyl cyclase) or ion channels. They "regulate" the flow of information by cycling between an active GTP-bound state and an inactive GDP-bound state. **Analysis of Options:** * **A. Membrane receptors:** G-proteins are not receptors themselves; they are peripheral membrane proteins located on the inner leaflet of the plasma membrane. They are activated *by* receptors (GPCRs), which are the actual ligand-binding sites. * **C. Second messengers:** G-proteins are signaling transducers. Second messengers are the small molecules produced *after* G-protein activation, such as cAMP, IP3, DAG, or Calcium. * **D. Membrane channels:** While G-proteins can regulate the opening and closing of ion channels, they do not form the pore or channel structure themselves. **High-Yield Clinical Pearls for NEET-PG:** * **Structure:** Heterotrimeric G-proteins consist of three subunits: **Alpha ($\alpha$), Beta ($\beta$), and Gamma ($\gamma$)**. The $\alpha$-subunit has intrinsic GTPase activity. * **Cholera Toxin:** Causes ADP-ribosylation of the **Gs** subunit, inhibiting its GTPase activity. This leads to constitutive activation of Adenylyl cyclase, high cAMP, and "rice-water" diarrhea. * **Pertussis Toxin:** Inhibits the **Gi** subunit (inhibitory G-protein), preventing it from inhibiting Adenylyl cyclase, leading to increased cAMP levels in the respiratory tract. * **Ras Protein:** A well-known "Small G-protein" (monomeric) involved in cell growth; mutations in Ras are frequently linked to human cancers.

Q: FSH, LH, and TSH act through which mechanism?

Cyclic AMP. **Explanation:** The hormones **FSH (Follicle-Stimulating Hormone), LH (Luteinizing Hormone), and TSH (Thyroid-Stimulating Hormone)**, along with ACTH and Glucagon, utilize the **G-protein coupled receptor (GPCR) – Adenylate Cyclase pathway**. When these hormones bind to their specific membrane receptors, they activate the Gs-protein, which in turn stimulates the enzyme Adenylate Cyclase. This enzyme converts ATP into **Cyclic AMP (cAMP)**, which acts as the **second messenger** to activate Protein Kinase A (PKA), leading to the desired cellular response. **Analysis of Options:** * **Option A (Correct):** cAMP is the definitive second messenger for these glycoprotein hormones. * **Option B (Incorrect):** Cyclic GMP (cGMP) is the second messenger for Atrial Natriuretic Peptide (ANP) and Nitric Oxide (NO). * **Option C (Incorrect):** While Adenylate Cyclase is involved in the pathway, it is the **effector enzyme**, not the second messenger itself. The question asks for the mechanism/messenger through which they act. * **Option D (Incorrect):** Calcium/IP3/DAG pathways are utilized by hormones like Oxytocin, TRH, and GnRH (the "Gq" protein pathway). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for cAMP:** "FLAT ChAMP" (FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2 receptor), MSH, PTH). * **Mnemonic for IP3/DAG:** "GOAT" (GnRH, Oxytocin, ADH (V1 receptor), TRH). * **Insulin and Growth Factors** primarily use **Receptor Tyrosine Kinase** pathways. * **Steroid and Thyroid hormones** (T3/T4) act via **Intracellular/Nuclear receptors** because they are lipophilic.

Q: Which of the following is a membrane-bound enzyme that catalyzes the formation of cyclic AMP from ATP?

Adenylate cyclase. **Explanation:** **1. Why Adenylate Cyclase is Correct:** Adenylate cyclase (AC) is a membrane-bound enzyme that plays a pivotal role in the G-protein coupled receptor (GPCR) signaling pathway. When a ligand (like epinephrine or glucagon) binds to a Gs-protein-coupled receptor, the α-subunit of the G-protein activates adenylate cyclase. This enzyme then catalyzes the conversion of **ATP into cyclic AMP (cAMP)**, which acts as a second messenger to activate Protein Kinase A (PKA). **2. Why the Other Options are Incorrect:** * **Tyrosine Kinase:** These are receptors (like the Insulin receptor) or non-receptor proteins that phosphorylate tyrosine residues on target proteins. They do not produce cAMP. * **Polymerase:** These enzymes (DNA or RNA polymerase) are involved in the synthesis of nucleic acids (replication and transcription) and are primarily located in the nucleus or mitochondria. * **ATP Synthase:** Located in the inner mitochondrial membrane, this enzyme complex synthesizes ATP from ADP and inorganic phosphate using the proton gradient (Oxidative Phosphorylation); it does not break down ATP to form cAMP. **3. NEET-PG High-Yield Clinical Pearls:** * **Termination of Signal:** The action of cAMP is terminated by the enzyme **Phosphodiesterase (PDE)**, which converts cAMP into 5'-AMP. Drugs like Theophylline and Caffeine inhibit PDE, thereby increasing cAMP levels. * **Bacterial Toxins:** *Vibrio cholerae* toxin causes permanent activation of Gs (via ADP-ribosylation), leading to constitutive activation of adenylate cyclase, high cAMP, and secretory diarrhea. * **Second Messengers:** Remember that while cAMP is the second messenger for AC, **IP3 and DAG** are the second messengers for the Phospholipase C (PLC) pathway.

Q: "Brain Natriuretic Peptide" is degraded by:

Neutral endopeptidase. **Explanation:** **1. Why Neutral Endopeptidase (NEP) is correct:** Brain Natriuretic Peptide (BNP), along with Atrial Natriuretic Peptide (ANP), is a hormone involved in cardiovascular homeostasis by promoting natriuresis and vasodilation. These peptides are primarily degraded by **Neutral Endopeptidase (NEP)**, also known as **Neprilysin**. NEP is a zinc-dependent metalloendopeptidase found in various tissues, particularly the kidneys. By cleaving the peptide bonds of natriuretic peptides, NEP terminates their biological action. **2. Why the other options are incorrect:** * **Elastase:** This is a protease that breaks down elastin in connective tissue. While clinically relevant in conditions like emphysema (Alpha-1 antitrypsin deficiency), it does not play a role in BNP metabolism. * **Collagenase:** This enzyme breaks the peptide bonds in collagen. It is involved in wound healing and tissue remodeling, not hormone degradation. * **Omeprazole:** This is a pharmacological agent (Proton Pump Inhibitor) used to inhibit gastric acid secretion. It is not an enzyme and has no degradative effect on peptides. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Sacubitril:** This is a potent **Neprilysin inhibitor**. When combined with Valsartan (an ARB), it forms the drug class **ARNI** (Angiotensin Receptor-Neprilysin Inhibitor), which is now a cornerstone in the management of Heart Failure with reduced Ejection Fraction (HFrEF). * **Diagnostic Marker:** While BNP is degraded by NEP, **NT-proBNP** (the N-terminal fragment) is not a substrate for Neprilysin. Therefore, in patients taking Sacubitril, BNP levels will be falsely elevated, making **NT-proBNP** the preferred marker for monitoring heart failure. * **Second Pathway:** Apart from NEP, natriuretic peptides are also cleared via **Natriuretic Peptide Receptor-C (NPR-C)** through receptor-mediated endocytosis.

Q: Which of the following signals directs a protein to the lysosomes?

Attached carbohydrate with terminal mannose-6-phosphate. ### Explanation **Correct Answer: C. Attached carbohydrate with terminal mannose-6-phosphate** The targeting of acid hydrolases (enzymes) to the **lysosome** is a post-translational modification process occurring in the Golgi apparatus. Enzymes destined for lysosomes are tagged with **Mannose-6-Phosphate (M6P)**. Specific M6P receptors in the Trans-Golgi Network (TGN) recognize this tag and package these proteins into clathrin-coated vesicles for transport to the late endosomes/lysosomes. **Analysis of Incorrect Options:** * **A. KDEL Sequence:** This tetrapeptide (Lys-Asp-Glu-Leu) is a retrieval signal for soluble proteins belonging to the **Endoplasmic Reticulum (ER)**. It ensures that ER-resident proteins that escape to the Golgi are captured and sent back to the ER via COPI vesicles. * **B. Dolichol Phosphate:** This is a long-chain lipid molecule located in the ER membrane. It acts as a membrane-bound carrier for the assembly of the core oligosaccharide during **N-linked glycosylation**, but it does not serve as a targeting signal. * **D. Terminal Mannose:** While mannose is a component of many glycoproteins, it is the **phosphorylation** at the 6th position (M6P) that specifically signals lysosomal trafficking. Terminal mannose residues on circulating proteins are often recognized by receptors on macrophages for clearance. **Clinical Pearls for NEET-PG:** * **I-Cell Disease (Mucolipidosis II):** Caused by a deficiency of **N-acetylglucosamine-1-phosphotransferase**. Without this enzyme, M6P tags cannot be added. Consequently, lysosomal enzymes are constitutively secreted into the extracellular space rather than being directed to lysosomes, leading to inclusion bodies and severe developmental symptoms. * **Vesicle Transport:** Remember the "Coat" proteins: **COPI** (Retrograde: Golgi to ER), **COPII** (Anterograde: ER to Golgi), and **Clathrin** (TGN to Lysosomes/Plasma membrane).

Q: Where are receptors of glucocorticoids typically located?

Cytosol. **Explanation:** **1. Why Cytosol is Correct:** Glucocorticoids (like cortisol) are lipophilic steroid hormones that easily diffuse across the lipid bilayer of the cell membrane. Once inside the cell, they bind to **Glucocorticoid Receptors (GR)**, which are primarily located in the **cytosol**. In their inactive state, these receptors are bound to **Heat Shock Proteins (HSP-90)**, which mask the receptor's DNA-binding domain. Upon ligand binding, the HSP dissociates, and the hormone-receptor complex dimerizes and translocates into the nucleus to act as a transcription factor. **2. Why Other Options are Incorrect:** * **DNA:** While the hormone-receptor complex eventually binds to specific DNA sequences called **Glucocorticoid Response Elements (GREs)**, the receptor itself is not "located" on the DNA in its basal state. * **Nucleus:** This is the location for receptors of **Thyroid hormones (T3/T4)**, Retinoic acid, and Vitamin D. Unlike glucocorticoids, these receptors are already bound to DNA even in the absence of a ligand. (Note: Estrogen and Progesterone receptors are also primarily nuclear). * **Cell Surface:** This is the site for water-soluble ligands (e.g., Peptide hormones like Insulin, Catecholamines) that cannot cross the cell membrane and require secondary messengers. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Receptor Location:** * **C**ytosolic: **C**ortisol (Glucocorticoids), Aldosterone (Mineralocorticoids). * **N**uclear: **N**on-steroids like Thyroid hormone, Vitamin D, and Retinoic acid. * **Mechanism:** Glucocorticoids regulate gene expression via **Zinc-finger motifs** in their DNA-binding domain. * **Clinical Link:** The dissociation of HSP-90 is a crucial step for receptor activation; drugs targeting HSPs are currently being researched for various endocrine disorders.

Q: Which of the following is NOT a secondary messenger?

Plasmalogen. **Explanation:** **1. Why Plasmalogen is the Correct Answer:** Plasmalogens are a specific class of **ether phospholipids** found abundantly in the myelin sheath of the brain and the membranes of the heart. They are **structural components** of cell membranes rather than signaling molecules. Unlike secondary messengers, they do not relay signals from receptors to target molecules within the cell. **2. Analysis of Incorrect Options (Secondary Messengers):** * **cAMP (Cyclic Adenosine Monophosphate):** The most common secondary messenger, activated by Adenylyl Cyclase. it primarily activates Protein Kinase A (PKA). * **cGMP (Cyclic Guanosine Monophosphate):** Produced by Guanylyl Cyclase, it mediates the effects of Nitric Oxide (NO) and Atrial Natriuretic Peptide (ANP). It activates Protein Kinase G (PKG). * **IP3 (Inositol Trisphosphate):** Derived from the cleavage of PIP2 by Phospholipase C (PLC). It binds to receptors on the Endoplasmic Reticulum to trigger the release of **Calcium (Ca²⁺)**, which is also a major secondary messenger. **3. High-Yield Clinical Pearls for NEET-PG:** * **Zellweger Syndrome:** A peroxisomal disorder characterized by the inability to synthesize plasmalogens, leading to severe neurological deficits. * **DAG (Diacylglycerol):** Often paired with IP3; it remains in the membrane to activate Protein Kinase C (PKC). * **Receptor Tyrosine Kinases (RTK):** These (e.g., Insulin receptor) often bypass traditional secondary messengers by using phosphorylation cascades (MAPK pathway). * **Memory Trick:** Common secondary messengers include **cAMP, cGMP, IP3, DAG, and Ca²⁺.** If it’s a structural lipid or a primary hormone, it is NOT a secondary messenger.

Q: What is LATS?

IgG. **Explanation:** **LATS (Long-Acting Thyroid Stimulator)** is a clinical term used to describe autoantibodies found in the serum of patients with **Graves' disease**. **Why IgG is the Correct Answer:** LATS is biochemically identified as an **Immunoglobulin G (IgG)**. These are autoantibodies (specifically Thyroid Stimulating Immunoglobulins or TSI) that bind to and activate the **TSH receptors** on the thyroid follicular cells. Unlike the physiological TSH, which is rapidly degraded, LATS has a prolonged duration of action—hence the name "Long-Acting." By mimicking TSH, LATS stimulates the adenylate cyclase-cAMP pathway, leading to excessive production of thyroid hormones (T3 and T4) and the characteristic hyperthyroidism of Graves' disease. **Why Other Options are Incorrect:** * **IgM & IgA:** While these are classes of immunoglobulins, they are not involved in the pathogenesis of Graves' disease. LATS is specifically an IgG because it is a high-affinity, monomeric antibody capable of crossing the placenta. * **Glycoprotein:** While the TSH *receptor* and TSH *hormone* are glycoproteins, LATS itself is an antibody (protein). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** LATS acts via **Type II Hypersensitivity** (Antibody-mediated cellular dysfunction). * **Placental Transfer:** Because LATS is an **IgG**, it can cross the placenta, leading to **Neonatal Thyrotoxicosis** in infants born to mothers with Graves' disease. * **Signal Transduction:** It activates the **Gαs protein**, increasing intracellular **cAMP**. * **Diagnostic Significance:** Detection of LATS/TSI is highly specific for the diagnosis of Graves' disease.

Q: Which of the following is the most important effector pathway for the action of Nitric Oxide?

Guanylate cyclase pathway. ### Explanation **Correct Option: C. Guanylate cyclase pathway** Nitric Oxide (NO) is a unique gaseous signaling molecule that acts as a potent vasodilator. Unlike most hormones that bind to membrane receptors, NO diffuses across the cell membrane and binds directly to **Soluble Guanylate Cyclase (sGC)** in the cytoplasm. This binding activates the enzyme, which converts GTP into **cyclic GMP (cGMP)**. Increased cGMP then activates **Protein Kinase G (PKG)**, leading to the dephosphorylation of myosin light chains and subsequent smooth muscle relaxation. **Why Incorrect Options are Wrong:** * **A. Adenylate cyclase pathway:** This pathway involves the conversion of ATP to cAMP (e.g., via Glucagon or Beta-adrenergic receptors). NO does not utilize cAMP as a second messenger. * **B. Phosphatidylinositol pathway:** This involves Phospholipase C (PLC) and the generation of IP3 and DAG (e.g., via Alpha-1 receptors). This pathway typically increases intracellular calcium, which opposes the relaxant effect of NO. * **C. MAP Kinase pathway:** This is primarily associated with growth factors and insulin signaling, focusing on cell proliferation and differentiation rather than acute vasodilation. **High-Yield Clinical Pearls for NEET-PG:** * **Nitroglycerin/Nitroprusside:** These drugs act as "NO donors" to treat angina and hypertensive emergencies via the cGMP pathway. * **Sildenafil (Viagra):** It inhibits **Phosphodiesterase-5 (PDE-5)**, the enzyme responsible for breaking down cGMP, thereby prolonging the effects of NO. * **Endothelial NO Synthase (eNOS):** NO is synthesized from the amino acid **L-Arginine** by the enzyme NO synthase (NOS), requiring NADPH and Oxygen as cofactors.

Question 1

What is a zinc finger?

Accepted Answer

Nuclear receptor

Answer

Membrane receptor

Answer

Receptor associated kinase

Answer

All of the above

Question 2

What are G-proteins?

Accepted Answer

Membrane regulators

Answer

Membrane receptors

Answer

Second messengers

Answer

Membrane channels

Question 3

FSH, LH, and TSH act through which mechanism?

Accepted Answer

Cyclic AMP

Answer

Cyclic GMP

Answer

Adenylate cyclase

Answer

Calcium release

Question 4

Which of the following is a membrane-bound enzyme that catalyzes the formation of cyclic AMP from ATP?

Accepted Answer

Adenylate cyclase

Answer

Tyrosine kinase

Answer

Polymerase

Answer

ATP synthase

Question 5

"Brain Natriuretic Peptide" is degraded by:

Accepted Answer

Neutral endopeptidase

Answer

Elastase

Answer

Collagenase

Answer

Omeprazole

Question 6

Which of the following signals directs a protein to the lysosomes?

Accepted Answer

Attached carbohydrate with terminal mannose-6-phosphate

Answer

A lys-asp-glu-leu (KDEL) sequence in the protein

Answer

Dolichol phosphate

Answer

Attached carbohydrate with terminal mannose

Question 7

Where are receptors of glucocorticoids typically located?

Accepted Answer

Cytosol

Answer

DNA

Answer

Nucleus

Answer

Cell surface

Question 8

Which of the following is NOT a secondary messenger?

Accepted Answer

Plasmalogen

Answer

cAMP

Answer

cGMP

Answer

IP3

Question 9

What is LATS?

Accepted Answer

IgG

Answer

IgM

Answer

Glycoprotein

Answer

IgA

Question 10

Which of the following is the most important effector pathway for the action of Nitric Oxide?

Accepted Answer

Guanylate cyclase pathway

Answer

Adenylate cyclase pathway

Answer

Phosphatidylinositol pathway

Answer

MAP Kinase pathway

Signal Transduction — MCQs

Signal Transduction — MCQs

On this page

Practice by Chapter

Want unlimited practice?